Copyright
©The Author(s) 2004.
World J Gastroenterol. Nov 1, 2004; 10(21): 3112-3117
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3112
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3112
Table 4 Comparison of the recurrent rates between groups
| Group | Total | Recurrent rate in situ (%) | Recurrent rate in dystopia (%) | ||||||
| Cases | 1 yr | 2 yr | 3 yr | 4 yr | 1 yr | 2 yr | 3 yr | 4 yr | |
| > 3 cm (A) | 58 | 6.9 (4/58) | 7.1 (3/42) | 24.2 (8/33) | 28.6 (6/21) | 15.5 (9/58) | 21.4 (9/42) | 36.4 (12/33) | 52.4 (11/21) |
| ≤ 3 cm (B) | 64 | 0 (0/64)a | 2.1 (1/48) | 5.1 (2/39)a | 4.2 (1/24)a | 9.0 (6/64) | 10.4 (5/48) | 12.8 (5/39)a | 20.8 (5/24)a |
- Citation: Lin LW, Lin XY, He YM, Gao SD, Xue ES, Lin XD, Yu LY. Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma. World J Gastroenterol 2004; 10(21): 3112-3117
- URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3112.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i21.3112